Literature DB >> 12771417

Glycoproteins M and N of human herpesvirus 8 form a complex and inhibit cell fusion.

Shin Koyano1, Eng-Chun Mar1, Felicia R Stamey1, Naoki Inoue1.   

Abstract

Glycoproteins M (gM) and N (gN) are well conserved across the herpesvirus family and their involvement in virus penetration and egress is well described, especially for alphaherpesviruses. Because there was no previous study on the homologues of human herpesvirus 8 glycoproteins M (gM8) and N (gN8), we analysed their biochemical and functional characteristics. We found that: (i) gM8 aggregated following heat treatment; (ii) gM8 was a virion component; (iii) gM8 and gN8 were N-glycosylated; (iv) gM8 formed a specific complex with gN8; and (v) gN8 was required for functional processing of gM8. Co-expression of gM8 and gN8 inhibited cell fusion induced either by a combination of herpes simplex virus type 1 glycoproteins or by Molony murine leukaemia virus envelope protein. These results indicate that, in addition to the similar biochemical properties, the fusion inhibition reported previously only for alphaherpesviruses is a function conserved in the gammaherpesvirus subfamily.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771417     DOI: 10.1099/vir.0.18941-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  53 in total

1.  Analysis of the requirement for glycoprotein m in herpes simplex virus type 1 morphogenesis.

Authors:  Helena Browne; Susanne Bell; Tony Minson
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Glycoprotein gene sequence variation in rhesus monkey rhadinovirus.

Authors:  Young C Shin; Leandro R Jones; Julieta Manrique; William Lauer; Angela Carville; Keith G Mansfield; Ronald C Desrosiers
Journal:  Virology       Date:  2010-02-20       Impact factor: 3.616

Review 3.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

4.  Glycoprotein M of herpes simplex virus 1 is incorporated into virions during budding at the inner nuclear membrane.

Authors:  Joel D Baines; Elizabeth Wills; Robert J Jacob; Janice Pennington; Bernard Roizman
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

5.  The carboxy-terminal domain of glycoprotein N of human cytomegalovirus is required for virion morphogenesis.

Authors:  Michael Mach; Karolina Osinski; Barbara Kropff; Ursula Schloetzer-Schrehardt; Magdalena Krzyzaniak; William Britt
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

6.  Virion proteins of Kaposi's sarcoma-associated herpesvirus.

Authors:  Fan Xiu Zhu; Jae Min Chong; Lijun Wu; Yan Yuan
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 7.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

8.  Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells.

Authors:  Harinivas H Krishnan; Neelam Sharma-Walia; Ling Zeng; Shou-Jiang Gao; Bala Chandran
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay.

Authors:  Yoshiko Fukui; Keiko Shindoh; Yumiko Yamamoto; Shin Koyano; Isao Kosugi; Toyofumi Yamaguchi; Ichiro Kurane; Naoki Inoue
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

10.  Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells.

Authors:  R Subramanian; I Sehgal; O D'Auvergne; K G Kousoulas
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.